Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
43.35
-0.01 (-0.02%)
At close: Jul 24, 2026, 4:00 PM EDT
43.46
+0.11 (0.26%)
After-hours: Jul 24, 2026, 7:53 PM EDT
Sanofi Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 47,354 | 46,716 | 44,286 | 41,618 | 40,561 | 39,175 |
Revenue Growth | 2.09% | 5.49% | 6.41% | 2.61% | 3.54% | 4.83% |
Gross Profit Gross Profit Growth | 34,055 | 33,667 | 31,081 | 28,990 | 28,679 | 26,920 |
Operating Income Operating Income Growth | 6,179 | 6,344 | 7,252 | 6,960 | 10,162 | 8,126 |
Net Income Net Income Growth | 7,554 | 7,813 | 5,560 | 5,400 | 8,371 | 6,223 |
Earnings Per Share EPS Growth | 3.11 | 3.19 | 2.21 | 2.15 | 3.33 | 2.48 |
EPS Growth | 22.93% | 43.79% | 3.02% | -35.44% | 34.54% | -49.28% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dupixent Dupixent Growth | 16,404 | 15,714 | 13,072 | 10,715 | 8,293 | 5,249 |
Pharma Pharma Growth | 36,338 | 35,690 | 32,783 | - | - | - |
Total Vaccine Total Vaccine Growth | 7,902 | 7,936 | 8,298 | 7,474 | 7,229 | 6,323 |
Revenue (Total) Revenue (Total) Growth | 47,354 | 46,716 | 44,286 | 41,618 | 40,561 | 39,175 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 5,544 | 7,657 | 7,441 | 8,710 | 12,736 | 10,098 |
Total Debt Total Debt Growth | 20,021 | 20,329 | 17,906 | 18,422 | 21,212 | 22,414 |
Net Cash (Debt) Net Cash Growth | -14,477 | -12,672 | -10,465 | -9,712 | -8,476 | -12,316 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.97 | -5.17 | -4.17 | -3.87 | -3.37 | -4.90 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 10,340 | 10,750 | 9,081 | 10,258 | 10,526 | 10,522 |
Capital Expenditures CapEx Growth | - | -3,538 | -3,195 | -2,906 | -2,103 | -2,043 |
Free Cash Flow Free Cash Flow Growth | 10,340 | 7,212 | 5,886 | 7,352 | 8,423 | 8,479 |
Free Cash Flow Growth | -6.73% | 22.53% | -19.94% | -12.72% | -0.66% | 182.07% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 71.92% | 72.07% | 70.18% | 69.66% | 70.71% | 68.72% |
Operating Margin | 13.05% | 13.58% | 16.38% | 16.72% | 25.05% | 20.74% |
Pretax Margin | 12.71% | 13.22% | 15.12% | 15.02% | 24.50% | 19.91% |
Profit Margin | 10.64% | 10.99% | 12.41% | 12.58% | 19.79% | 15.93% |
FCF Margin | 21.84% | 15.44% | 13.29% | 17.67% | 20.77% | 21.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.765 | 4.120 | 3.920 | 3.760 | 3.560 | 3.330 |
Dividend Per Share Growth | 10.40% | 5.10% | 4.25% | 5.62% | 6.91% | 4.06% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.95 | 12.97 | 20.93 | 20.93 | 13.56 | 17.80 |
P/FCF Ratio | 10.66 | 13.97 | 19.74 | 15.32 | 13.43 | 13.02 |
PS Ratio | 1.91 | 2.16 | 2.62 | 2.71 | 2.79 | 2.82 |